Accession Number : ADA319403
Title : The Role of Mutant P53 Protein in Breast Cancer.
Descriptive Note : Annual rept. 1 Aug 95-31 Jul 96,
Corporate Author : COLUMBIA UNIV NEW YORK
Personal Author(s) : Prives, Carol L.
PDF Url : ADA319403
Report Date : AUG 1996
Pagination or Media Count : 55
Abstract : Mutation of the p53 gene is very frequent in breast cancer. In normal cells induction of wild-type p53 function leads to either cell cycle arrest or cell death. Loss of this function can contribute to oncogenic cell transformation. Additionally the presence of mutant forms of p53 in breast tumor cells may actually facilitate the process of tumorigenesis. The properties of mutant p53 proteins in vitro and in breast tumor cell lines will be studied, experiments will focus on analysis of the structure and modification of mutant p53 proteins as well as the effect of cellular signalling on p53 function. Additionally it is planned to establish breast cell lines expressing inducible mutant p53 to determine the effect of such mutants on parameters of cell cycle, growth and death. We have discovered that all mutant forms of p53 tested are capable of binding specifically to p53 response elements present in pS3 target genes at lower but not at physiological temperatures. Furthermore, we have identified a means by which such binding is stabilized at the higher temperature. This will allow us to explore means to develop molecules that might have the outcome of converting p53 in breast tumor cells from mutant to wild-type in function. One approach will be to develop a yeast-based screen for mutant p53 modifying genes. Such reagents would have clear therapeutic advantages.
Descriptors : *GENES, *MAMMARY GLANDS, *BREAST CANCER, TEMPERATURE, PRODUCTION, MOLECULES, NEOPLASMS, CYCLES, MUTATIONS, IN VITRO ANALYSIS, SIGNALS, YEASTS, PHYSIOLOGY, DEATH, CELLS(BIOLOGY), INDUCTION SYSTEMS.
Subject Categories : Genetic Engineering and Molecular Biology
Medicine and Medical Research
Distribution Statement : APPROVED FOR PUBLIC RELEASE